Mar 4, 2026 08:19AM
Mar 4, 2026 08:15AM
Sep 30, 2025 06:05AM
Sep 18, 2025 11:02AM
Aug 13, 2025 06:27AM
Aug 1, 2025 08:33AM
Jul 21, 2025 07:30AM Ocugen adds retina experts to advisory board, names new executives
Jun 24, 2025 06:51AM
Jun 23, 2025 07:30AM
Jun 16, 2025 07:03AM
Jun 5, 2025 10:32AM
Jun 5, 2025 07:03AM
May 27, 2025 07:04AM
May 13, 2025 06:59AM Ocugen, Inc. (OCGN) PT Lowered to $7 at H.C. Wainwright
May 9, 2025 08:22AM
Mar 18, 2025 08:06AM
Mar 5, 2025 07:14AM
Mar 3, 2025 09:01AM
Feb 27, 2025 08:48AM
Feb 13, 2025 06:50AM
Feb 12, 2025 07:45AM Ocugen (OCGN) Announces Dosing Completion in the Phase 2 ArMaDa Clinical Trial for OCU410—a Multifunctional Modifier Gene Therapy for the Treatment of Geographic Atrophy Secondary to dAMD
Feb 3, 2025 06:31AM
Jan 27, 2025 06:31AM
Jan 13, 2025 06:31AM
Dec 19, 2024 06:40AM
Nov 20, 2024 07:33AM
Nov 19, 2024 07:03AM
Nov 8, 2024 06:53AM Ocugen (OCGN) reported Q3 Revenue
Oct 22, 2024 07:02AM
Oct 15, 2024 08:18AM
Oct 9, 2024 06:33AM
Aug 28, 2024 06:32AM
Aug 26, 2024 07:03AM
Aug 8, 2024 07:11AM
Aug 5, 2024 06:31AM Ocugen (OCGN) Announces FDA Approval of Expanded Access Program for Patients with Retinitis Pigmentosa
Aug 1, 2024 06:23AM
Jul 31, 2024 04:15PM
Jun 26, 2024 04:38AM
Jun 21, 2024 07:01AM

353,174 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All